You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 8,551,091


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,551,091
Title:Vessel sealing instrument with electrical cutting mechanism
Abstract: An end effector assembly for use with an instrument for sealing vessels and cutting vessels includes a pair of opposing first and second jaw members which are movable relative to one another from a first spaced apart position to a second position for grasping tissue therebetween. Each jaw member includes an electrically conductive tissue contacting surface connected to an electrosurgical energy source. At least one of the jaw members includes an electrically conductive cutting element disposed within an insulator defined in the jaw member. At least one channel is included in the insulator which is configured to deliver fluid between the jaw members.
Inventor(s): Couture; Gary M. (Longmont, CO), Weinberg; Craig (Denver, CO), Tetzlaff; Philip Mark (Austin, TX)
Assignee: Covidien AG (CH)
Application Number:13/075,847
Patent Claims:1. An end effector assembly for use with an instrument for sealing and/or cutting vessels and/or tissue, the end effector assembly comprising: a pair of opposing first and second jaw members at least one of which is movable relative to the other from a first position wherein the jaw members are disposed in spaced relation relative to one another to a second position wherein the jaw members cooperate to grasp tissue therebetween; each jaw member including a pair of spaced apart, electrically conductive tissue sealing surfaces extending along a length thereof, each tissue sealing surface being adapted to connect to a source of electrosurgical energy such that the tissue sealing surfaces are capable of conducting electrosurgical energy through tissue grasped therebetween to effect a seal; an insulator disposed between each pair of electrically conductive sealing surfaces; the first jaw member including an electrically conductive cutting element disposed within the insulator of the first jaw member, the electrically conductive cutting element disposed in general vertical registration to the insulator on the second jaw member; at least one channel defined within each of the insulators, the at least one channel configured to provide fluid adjacent to tissue held between the jaw members, wherein the at least one channel includes a plurality of channel portions configured to branch around the electrically conductive cutting element; and wherein the at least one channel further includes at least one port configured to provide fluid to the at least one channel.

2. An end effector assembly according to claim 1, wherein the fluid includes at least one of a conductive fluid, a non-conductive fluid, and combinations thereof.

3. An end effector assembly according to claim 1, wherein the at least one channel is in communication with at least one pump.

4. An end effector assembly according to claim 1, wherein the electrically conductive tissue sealing surfaces of opposing jaw members are disposed in an angular relationship relative to one another.

5. An end effector assembly according to claim 1, wherein a distal end of each of the plurality of channel portions terminates in an orifice.

6. An end effector assembly according to claim 5, wherein the orifice at the distal end of each of the plurality of channel portions is disposed substantially adjacent to the electrically conductive cutting element.

7. An end effector assembly according to claim 1, wherein the plurality of channel portions is configured to transport fluid for irrigating tissue adjacent to both sides of the electrically conductive cutting element.

8. An end effector assembly according to claim 7, wherein each of the plurality of channel portions terminates in an orifice disposed substantially adjacent to the electrically conductive cutting element.

9. An end effector assembly according to claim 7, wherein the plurality of channel portions includes a first channel portion and a second channel portion, the first channel portion terminating in a first orifice disposed substantially adjacent to a first side of the electrically conductive cutting element, the second channel portion terminating in a second orifice disposed substantially adjacent to a second side opposite to the first side of the electrically conductive cutting element.

10. A method of modifying the conductivity of tissue during an electrosurgical procedure comprising: providing an end effector assembly, comprising: a pair of opposing first and second jaw members each including an electrically conductive tissue sealing surface extending along a length thereof; an insulative support element configured to support each electrically conductive sealing surface; an electrically conductive cutting element disposed within at least one insulative support element of one of the jaw members; and at least one channel disposed within the insulative support element, the at least one channel including a plurality of channel portions configured to transport fluid for irrigating tissue adjacent to both sides of the electrically conductive cutting element; and selectively adjusting an amount of fluid during an electrosurgical procedure.

11. The method in accordance with claim 10, wherein the step of selectively adjusting the amount of fluid includes one of adding fluid or removing fluid.

12. The method in accordance with claim 10, wherein the fluid is at least one of a conductive fluid, a non-conductive fluid, and combinations thereof.

13. The method in accordance with claim 12, wherein the fluid is conductive and is at least one of an aqueous solution, a saline solution, a salt solution, an electrolyte containing solution, and combinations thereof.

14. The method in accordance with claim 12, wherein the fluid is non-conductive fluid and comprises at least one of an aqueous solution, a solution having 1.5% glycine, a solution having 3% sorbitol, a solution having 5% mannitol, a solution of sterile water, and combinations thereof.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.